Skip to main content
. 2009 May;157(1):44–54. doi: 10.1111/j.1476-5381.2009.00236.x

Table 3.

Pharmacokinetic properties of A-940894

Species Route of administration and dose (mg·kg1) t1/2(h) Cmax(µmol·L1) Vβ(L·kg1) F (%)
Mouse i.v. (5) 4.9 0.71 88.9
p.o. (10) 6.8 0.13 33
s.c. (10) 3.3 2.52
Rat i.v. (10) 2.2 4.16 20
p.o. (10) 3.4 0.51 37
i.p. (10) 3.1 1.63 78